Literature DB >> 23770967

Vancomycin-resistant Enterococcus faecium of multi locus sequence type 18 in Malaysia.

L W Poh1, A W Rukman, Y K Cheah, Z Norital, A M Nazri, N S Mariana.   

Abstract

Vancomycin-resistant Enterococcus faecium (VREF) in human infections mostly belong to the high-risk, epidemic, clonal complex-17 (CC17) group. Treatment limitation and high conjugation frequency makes it dominant in hospitals worldwide. We investigated positive cultures by Pulse-field gel electrophoresis (PFGE), multi locus sequence typing (MLST). DNA of two strains (A2 and C) appeared to be clonally related by PFGE. Three strains were of ST 18 type (A1, B and C) and strain A2 is of a new ST 596. This ST 18 type strain found in our study is crucial and is believed to be the first in Malaysia.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23770967

Source DB:  PubMed          Journal:  Med J Malaysia        ISSN： 0300-5283


  3 in total

Review 1.  Public Health Risks of Multiple-Drug-Resistant Enterococcus spp. in Southeast Asia.

Authors:  Diane Sunira Daniel; Sui Mae Lee; Gary A Dykes; Sadequr Rahman
Journal:  Appl Environ Microbiol       Date:  2015-07-06       Impact factor: 4.792

2.  Molecular analysis and distribution of multidrug-resistant Enterococcus faecium isolates belonging to clonal complex 17 in a tertiary care center in Mexico City.

Authors:  Sara A Ochoa; Gerardo Escalona; Ariadnna Cruz-Córdova; Leticia B Dávila; Zeus Saldaña; Vicenta Cázares-Domímguez; Carlos A Eslava; Briceida López-Martínez; Rigoberto Hernández-Castro; Guillermo Aquino-Jarquin; Juan Xicohtencatl-Cortes
Journal:  BMC Microbiol       Date:  2013-12-11       Impact factor: 3.605

3.  High genetic diversity of Enterococcus faecium and Enterococcus faecalis clinical isolates by pulsed-field gel electrophoresis and multilocus sequence typing from a hospital in Malaysia.

Authors:  Poh Leng Weng; Ramliza Ramli; Mariana Nor Shamsudin; Yoke-Kqueen Cheah; Rukman Awang Hamat
Journal:  Biomed Res Int       Date:  2013-05-29       Impact factor: 3.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.